stockrow
Wednesday 11 November 2026
Export REPL’s income statement to Excel — free account
Replimune Group, Inc.
REPL- EPS
- +39.7%
- Free cash flow
- +42.2%
- Total debt
- +74.3%
Quarter to September 2026, against a year earlier
21.88
1.40
−6.01%
Follow REPL
Alert me
Replimune Group, Inc. (REPL) Total debt
Replimune Group, Inc.'s total debt at the end of fiscal 2026 was $105.2M, up 52.3% from $69.1M in fiscal 2025. At the end of the quarter to 30 September 2026 it was $121.2M. Over the past ten years it has ranged from $6.6M (fiscal 2019) to $105.2M (fiscal 2026) — the current reading is the highest in ten years. Replimune Group, Inc. ranks 75th of 569 Biotechnology companies by total debt.
Total debt, annual
Embed this chart
Annual newest first
| Period | Total debt | Change |
|---|---|---|
| FY2026 | $105.2M | 52.25% |
| FY2025 | $69.1M | 1.30% |
| FY2024 | $68.2M | 29.66% |
| FY2023 | $52.6M | 115.57% |
| FY2022 | $24.4M | (1.37%) |
| FY2021 | $24.7M | (28.83%) |
| FY2020 | $34.8M | 429.92% |
| FY2019 | $6.6M | — |
Quarterly newest first
| Period | Total debt | Change |
|---|---|---|
| Sep 2026 | $121.2M | 14.57% |
| Jun 2026 | $105.8M | 0.55% |
| Mar 2026 | $105.2M | 50.83% |
| Dec 2025 | $69.8M | 0.30% |
| 28 more quarters | Free account |
Against its own ten years
Low $6.6M
High $105.2M
Ten-year median
$43.7M
Current reading's percentile
100
Total debt against peers
| Company | Total debt |
|---|---|
| VIR Vir Biotechnology, Inc. compare | $128.0M |
| REPL Replimune Group, Inc. | $121.2M |
| VERA Vera Therapeutics, Inc. compare | $75.2M |
| AUPH Aurinia Pharmaceuticals Inc compare | $39.0M |
| LKFT Lakefront Biotherapeutics - Sponsored ADR compare | $5.5M |
| ZYME Zymeworks Inc. compare | $278.0K |
| IMNM Immunome, Inc. compare | $228.0K |
| RXRX Recursion Pharmaceuticals, Inc. compare | $93.0K |
| TRAX First Tracks Biotherapeutics, Inc. compare | — |
What Total debt is
Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.
Long Term Debt (Total) + Current Part of Debt